Navigation Links
Diplomat Specialty Pharmacy Hires Rinku A. Patel, PharmD as Director of Pharmacy Development and Operations

SWARTZ CREEK, Mich., Nov. 3 /PRNewswire/ -- Diplomat Specialty Pharmacy today announced that Dr. Rinku A. Patel has joined the company's executive management team. Dr. Patel will serve as Director of Pharmacy Development and Operations. She will be responsible for the management and development of Diplomat's Chicago location and will closely collaborate with the executive team to develop and implement specialty pharmacy programs. Dr. Patel will directly report to Jeff Rowe, Sr. Vice President of Operations for Diplomat.

"Rinku brings extensive expertise in several key growth areas for Diplomat including RSV, Hemophilia, and Pharmacy technology," said Phil Hagerman, President and CEO of Diplomat Specialty Pharmacy. "Her experience in these core Specialty Pharmacy areas will support our continued national expansion and industry leading platform."

"I am thrilled to be part of Diplomat. They are the largest independently owned specialty pharmacy in the country and value patient care above everything else," said Dr. Patel. "I am looking forward to providing innovative and comprehensive specialty pharmacy solutions to address the needs of our Patients, Payors, Providers and Pharma partners."

Dr. Patel is a registered pharmacist with over 10 years of operational and strategic development experience in the areas of Specialty, Home Infusion, and Pharmacy Technology. Prior to joining Diplomat she was the Director of Procurement & Pharma Relations at OptionCare; and at Caremark, Dr. Patel was the Manager of Contracts and Trade Relations and served as an IT Pharmacist. Dr. Patel is a graduate of the Bachelors in Pharmacy and Doctor of Pharmacy programs at Midwestern University in Downers Grove, Illinois.

About Diplomat Specialty Pharmacy

Diplomat Specialty Pharmacy is the nation's largest independently held Specialty Pharmacy and focuses on complete medication management programs for patients with serious and chronic conditions. Key programs include: Oncology, HIV/AIDS, Hepatitis C, Multiple Sclerosis, Rheumatoid Arthritis, Crohn's and Psoriasis. Other specialty areas include Transplant, Fertility, Dialysis Medication Management, Bio-Identical Hormone Replacement Therapy and Specialty Compounding. The company also specializes in Disease Management programs for Chronic Kidney Disease patients, as well as Home and Out-Patient Infusion. With locations in Flint, Swartz Creek and Grand Rapids, MI; Cleveland, OH; Chicago, IL; and Ft. Lauderdale, Florida; Diplomat services the specialty pharmacy needs of patients and physicians nationwide.

For more information contact:

Kathy Karns


SOURCE Diplomat Specialty Pharmacy
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diplomats 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
2. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
3. Diplomat Specialty Pharmacy Hires National Accounts Manager to Expand Multiple Sclerosis Program
4. Diplomat Specialty Pharmacy Hires Vice President of Managed Markets
5. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
6. Stem Cell Transplantation Program at Hackensack University Medical Center: First in Nation to Receive Joint Commission Certification for Quality and First in New Jersey to be Named a Blue Distinction(R) Center for Specialty Care.
7. Anadys Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
8. Onyx Pharmaceuticals to Present at Bank of America 2008 Specialty Pharmaceuticals Conference
9. Idenix Pharmaceuticals to Present at the Bank of America 2008 Specialty Pharmaceuticals Conference
10. A Perfect Storm Threatens Patient Access to Specialty Medical Care
11. 60 Specialty Chemical, Fine Chemical & Custom Synthesis Providers Will Exhibit at Pharma ChemOutsourcing on September 8-9 in New Jersey
Post Your Comments:
(Date:6/23/2016)... ... June 23, 2016 , ... ... launch of the Supplyframe Design Lab . Located in Pasadena, Calif., the ... future of how hardware projects are designed, built and brought to market. , ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a ... discoveries to the medical community, has closed its Series ... Matthew Nunez . "We have received a ... the capital we need to meet our current goals," ... provide us the runway to complete validation on the ...
(Date:6/23/2016)... , June 23, 2016 On ... session at 4,833.32, down 0.22%; the Dow Jones Industrial Average ... 500 closed at 2,085.45, down 0.17%. has initiated coverage ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), Aralez ... Inc. (NASDAQ: BIND ). Learn more about these ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):